Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 25, 2005

Circulation. 2005
Published online before print July 25, 2005, doi: 10.1161/CIRCULATIONAHA.104.503938
A more recent version of this article appeared on August 2, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/5/691    most recent
CIRCULATIONAHA.104.503938v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grandel, U.
Right arrow Articles by Sibelius, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grandel, U.
Right arrow Articles by Sibelius, U.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Contractile function
Right arrow Other heart failure
Right arrow Animal models of human disease
Right arrow Physiological and pathological control of gene expression
Right arrow Other Vascular biology

Submitted on September 13, 2004
Revised on April 19, 2005
Accepted on April 22, 2005

Mechanisms of Cardiac Depression Caused by Lipoteichoic Acids From Staphylococcus aureus in Isolated Rat Hearts

Ulrich Grandel MD, Michael Hopf MD, Michael Buerke MD, Katja Hattar MD, Martina Heep , Ludger Fink MD, Rainer M. Bohle MD, Siegfried Morath PhD, Thomas Hartung MD, PhD, Soni Pullamsetti , Ralph T. Schermuly PhD, Werner Seeger MD, Friedrich Grimminger MD, PhD, and Ulf Sibelius MD*

From the Departments of Internal Medicine (U.G., M. Hopf, K.H., M. Heep, S.P., R.T.S., W.S., F.G., U.S.) and Pathology (L.F., R.M.B.), Justus Liebig University, Giessen; Department of Internal Medicine, Martin Luther University, Halle-Wittenberg (M.B.); and Department of Biochemical Pharmacology, University of Konstanz, Konstanz (S.M., T.H.), Germany.

* To whom correspondence should be addressed. E-mail: ulf.sibelius{at}innere.med.uni-giessen.de.

Background--Lipoteichoic acid (LTA) represents a major virulence factor in gram-positive sepsis.

Methods and Results--In the present study we perfused isolated rat hearts for 180 minutes with highly purified LTA from Staphylococcus aureus. A progressive decline of left ventricular contractile function paralleled by the expression of myocardial tumor necrosis factor-{alpha} (TNF-{alpha}) mRNA and protein as well as the release of TNF-{alpha} into the perfusate was observed in LTA-perfused hearts. Employment of an anti-TNF-{alpha} antibody completely prevented the loss in contractile function. When CD14, a prominent pathogen recognition receptor, was blocked by a specific antibody, induction of TNF-{alpha} mRNA and protein release as well as the associated cardiodepression was diminished in response to LTA. Synthesis of TNF-{alpha} protein was located to interstitial cells of LTA-challenged hearts as detected by immunohistochemistry. Besides progressive cardiodepression, coronary perfusion pressure (CPP) was moderately increased in LTA-perfused hearts. This was accompanied by the release of thromboxane A2 (TXA2) into the perfusate and the induction of cyclooxygenase (Cox)-2 mRNA and protein in the myocardium. Blocking of TXA2 by the nonspecific Cox inhibitor indomethacin, the thromboxane receptor antagonist daltroban, or the selective Cox-2 inhibitor NS-398 prevented the increase in CPP.

Conclusions--LTA causes cardiac depression by activating myocardial TNF-{alpha} synthesis via CD14 and induces coronary vascular disturbances by activating Cox-2-dependent TXA2 synthesis. These phenomena may contribute to cardiac depression in gram-positive sepsis.


Key words: heart failure • thromboxane • bacterial toxins • cytokines • sepsis




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Bucki, F. J. Byfield, A. Kulakowska, M. E. McCormick, W. Drozdowski, Z. Namiot, T. Hartung, and P. A. Janmey
Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components
J. Immunol., October 1, 2008; 181(7): 4936 - 4944.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M.W. Merx and C. Weber
Sepsis and the Heart
Circulation, August 14, 2007; 116(7): 793 - 802.
[Abstract] [Full Text] [PDF]